2015 AGENDA
THURSDAY, OCT 1, 2015
SPEAKERS AND TOPICS
Companies Represented in Panels:

2015 SYMPOSIUM RECAP
Dorsey 4D Symposium hosted life sciences industry leaders, including Google Life Sciences, Samsung, GE Ventures and China Bio. Keynote speaker Governor Michael Leavitt, three-time elected governor of Utah and former Secretary of Health and Human Services under President George W. Bush, offered a new perspective on life sciences and the future of healthcare.
![]() | ![]() | ![]() | ![]() |
---|---|---|---|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() |
2015 SPEAKERS
Gov. Michael O. Leavitt
Keynote SpeakerFormer Secretary of Health and Human Services; Founder and Chairman of Leavitt Partners
Kate Sharadin
Senior Director of Business Development and Strategy, Invention Science Funds – Intellectual Ventures2015 Agenda
9:10 AM - 9:35 AM
Macro Trends in Healthcare – Capitalizing on Opportunities
Dr. Trevor Hawkins, Senior Vice President – Strategy & Innovation, Siemens Healthcare Diagnostics
Evan Ng, Partner, Dorsey & Whitney LLP
The world’s aging population is continuing to expand. New processes and innovations are necessary to release the stress on the current healthcare system to support this dynamic. Join us as Dr. Trevor Hawkins of Siemens guides us through the macro trends in healthcare and illustrates, via his expertise and experience with drugs and diagnostics, ways to capitalize on unfolding opportunities to come.
9:35 AM - 10:05 AM
Managing Your Company through Adversity
Paul Buckman, President and Chief Executive Officer, Conventus Orthopaedics
Scott Smith, Partner, Dorsey & Whitney LLP
When Paul took over as CEO of Conventus Orthopaedics in October 2013, the company, founded in 2008, already had FDA clearance for its device but was almost completely out of money. Its original and largest investor was no longer investing in medical device startups, and no other investors were racing in to fill the void. $34 million investment dollars later, Conventus is thriving, with a new clinical direction and renewed interest from physicians. How did Paul turn around a company on the brink, in the ever-challenging world of medical devices? How do you reenergize employees and keep them excited after five, ten or even more years at a startup? In this interview with Paul, learn how he found interested investors for a company that was on the verge of closing its doors and kept employees motivated to take the company to the next level.
10:20 AM - 10:40 AM
Invention-Driven Commercialization – A Case Study
Kate Sharadin, Senior Director Business Development, Intellectual Ventures
Jennifer Spaith, Partner, Dorsey & Whitney LLP
Intellectual Ventures discusses their experience in catalyzing healthcare invention, building intellectual property portfolios, incubating start-up company opportunities and partnering for commercialization. IV’s activity in the medical technology and digital health spaces will be outlined. Partnering opportunities with IV will be discussed, together with exciting innovative developments both upcoming and currently available.
10:40 AM - 11:15AM
Inside Google Life Sciences – The Next Frontier in Healthcare
Brian Otis, Google Life Sciences
Jessica Linehan, Partner, Dorsey & Whitney LLP
Google has always had ambitions in healthcare. The company has clearly articulated the importance of its healthcare initiatives to the market with its recent Alphabet reorganization. Brian Otis of Google Life Sciences will demonstrate the Google Smart Contact Lens platform, and share his thoughts on the scarcity of power, extreme miniaturization, and end-to-end connected systems that span the design space from transistors to the cloud. Join us as we dig deep into one major example of Google Life Sciences’ entrees into healthcare.
12:10 PM - 1:10 PM
Keynote Address: Governor Michael Leavitt
Former Utah Governor and Secretary of Health and Human Services; Founder and Chairman of Leavitt Partners
1:20 PM - 2:00PM
Digital Health in the Real World – A Sneak Peek into the Future of Patient Care
Jerry Berger, Senior Manager, Healthcare | Vertical Business; Samsung Electronics America
Jeff Cooper, Business Development, Samsung MSCA
Jason Wisniewski, Partner, Dorsey & Whitney LLP
As one of the largest multinational conglomerate companies in the world, Samsung produces more than just smartphones. Their businesses span industries such as semiconductors, consumer electronics and appliances, ship building, advanced technology and medicine. During this panel and Q&A session, Samsung executives will share the company’s growing interest in healthcare and provide a sneak peek into some of their initiatives to facilitate real world use cases with health software, health service platforms on consumer devices and future hardware components for healthcare devices.
2:00 PM - 2:30 PM
California Institute for Regenerative Medicine 2.0 – Partnering Opportunities
Kevin McCormack, Senior Director Public Communications & Patient Advocate Outreach, CIRM
Neil Littmann, Business Development Manager, CIRM
Dr. Gil Sambrano, Science Officer, CIRM
David Walker, Partner, Dorsey & Whitney LLP
The California Institute for Regenerative Medicine (CIRM; also known as California's Stem Cell Agency) governs the allocation of the $3 Billion authorized to fund stem cell research in California. Panelists from CIRM will discuss the agency's history, its mission, the recent implementation of CIRM 2.0, how companies can apply for funding from CIRM and what they can do to help maximize their success.
2:50 PM - 3:30 PM
Traditional and Corporate Venture Capital – An Insider’s View
Rowan Chapman, Managing Director – New Business Creation, GE Ventures
Evan Ng, Partner, Dorsey & Whitney LLP
While traditional VCs continue to be the go-to path for startup funding, corporate VCs are increasingly gaining popularity. In this session, Rowan Chapman, who spent 11 years as a Partner at Mohr Davidow Ventures before joining GE Ventures, shares her experiences from both types of VCs. She will provide insight into how traditional and corporate VCs function, their sometimes divergent motivations, how to pitch to CVC and VCs and what entrepreneurs need to know when choosing between the two.
3:30 PM - 4:20 PM
Chinese-Financed Healthcare Investments – Current Trends, Domestic and International
Greg Scott, Founder and Chairman, ChinaBio Group
Chen Yu, Managing Partner, Vivo Capital
Nick Pliam, Principal, Decheng Capital
Sofie Qiao, Venture Partner, WuXi Healthcare Ventures II & CEO, WuXi Portofolio Company
Jimmy Zhang, Vice President, Transactions, Johnson & Johnson Innovation
John Chase, Partner, Dorsey & Whitney LLP
China is consistently top of mind for entrepreneurs seeking commercial and investment opportunities. With the recent stock market and currency turmoil in China, get an up to the minute view from experienced China operatives who will share their insights on what’s hot, what’s not, and how to get things done in this tumultuous time.
4:30 PM - 5:30 PM
Networking Reception